Cue Biopharma (CUE) Stock Price, Quote, News & History

SPY774.53−0.35%QQQ753.43−0.57%BTC/USD80,970.87−2.77%DIA509.15−0.37%GLD376.94+0.28%TLT77.23+0.10%

Premium

Cue Biopharma Inc (CUE) Stock Price, Quote, News & History

CUENASDAQ

Trade with Public

$22.79

0.281.24%

Last update: Oct 8, 9:11 AM

$22.79

0.281.24%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$22.38

Volume / Avg.

48.92K / 263.75K

Day Range

$21.60 - $22.57

52 Wk Range

4.97 - 45.50

Market Cap

$165.55M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.8%

Days to Cover

2.44

Recent Cue Biopharma, Inc. News

What's Going on With Cue Biopharma Stock on Monday?

Cue Biopharma reports Phase 2 CUE-221 trial results in chronic hives, showing strong efficacy and favorable safety.

Vandana Singh

Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket

Lobo Technologies shares surged 32% premarket after a narrower H1 loss and higher sales; several small caps rallied while others fell sharply.

Avi Kapoor

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts initiated bullish coverage on TRAX, BGSI, NPCE, CUE and NGVC, assigning Outperform/Buy ratings with price targets from $18 to $120.

Avi Kapoor

Why Twilio Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Twilio Inc (NYSE: TWLO) reported strong Q1 results and raised future sales guidance above estimates, causing shares to jump 20.6% in pre-market trading. Other gainers include CUE, SST, AKAN, XXII, SDOT, TEAM, ISPC, and FIVN, while BAFN, RBLX, SKBL, and RNTX were among the losers.

Avi Kapoor

Cue Biopharma Stock Surges Over 65% Overnight: Why Is It Moving?

Cue Biopharma Inc. shares surged 67.57% after announcing a $30M financing, anti-IgE antibody license, and new CEO.

Mohd Haider

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-50.05M

Investing Cash Flow (TTM)

131.00K

Financing Cash Flow (TTM)

39.82M

Free Cash Flow (TTM)

-50.17M

Capital Expenditure (TTM)

-121.00K

Net Change in Cash (TTM)

-10.10M

Analyst Trends and Forecast

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$148.99M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.70

PB Ratio (TTM)

70.69

Earnings Yield % (TTM)

-131.05%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.32

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$2.50M

Total Cash

$17.39M

Debt to Equity

1.33

Issuance of Debt (TTM)

-$2.50M

Repayment of Debt (TTM)

-$2.50M

Key Statistics

Open

$22.38

Volume / Avg.

48.92K / 263.75K

Day Range

$21.60 - $22.57

52 Wk Range

4.97 - 45.50

Market Cap

$165.55M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.8%

Days to Cover

2.44

About Cue Biopharma Inc

Sector

Health Care

Industry

Biotechnology

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy Cue Biopharma (CUE) stock?

You can purchase shares of Cue Biopharma (NASDAQ:CUE) through any online brokerage.

View our list of the best stock brokerages

Who are Cue Biopharma (CUE) competitors?

Other companies in Cue Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).

What is the forecast, or price target, for Cue Biopharma (CUE) stock?

Cue Biopharma has a consensus price target of $126.63.

What is the current price for Cue Biopharma (CUE)?

The stock price for Cue Biopharma (NASDAQ: CUE) is $22.7885 last updated October 8, 2026 at 9:11 AM EDT.

Does Cue Biopharma (CUE) pay a dividend?

There are no upcoming dividends for Cue Biopharma.

When is Cue Biopharma (NASDAQ:CUE) reporting earnings?

Cue Biopharma does not have any upcoming earnings scheduled.

Is Cue Biopharma (CUE) going to split?

There is no upcoming split for Cue Biopharma.

What sector and industry does Cue Biopharma (CUE) operate in?

Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cue Biopharma Inc (CUE) Stock Price, Quote, News & History

Cue Biopharma (CUE) Stock Price, Quote, News & History | Benzinga

Key Statistics

Recent Cue Biopharma, Inc. News

What's Going on With Cue Biopharma Stock on Monday?

Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Why Twilio Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Cue Biopharma Stock Surges Over 65% Overnight: Why Is It Moving?

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About Cue Biopharma Inc

Edge Rankings

Stock Score Locked: Want to See it?

FAQ

How do I buy Cue Biopharma (CUE) stock?

Who are Cue Biopharma (CUE) competitors?

What is the forecast, or price target, for Cue Biopharma (CUE) stock?

What is the current price for Cue Biopharma (CUE)?

Does Cue Biopharma (CUE) pay a dividend?

When is Cue Biopharma (NASDAQ:CUE) reporting earnings?

Is Cue Biopharma (CUE) going to split?

What sector and industry does Cue Biopharma (CUE) operate in?

Key Statistics

Recent Cue Biopharma, Inc. News

What's Going on With Cue Biopharma Stock on Monday?

Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Why Twilio Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Cue Biopharma Stock Surges Over 65% Overnight: Why Is It Moving?

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About Cue Biopharma Inc

Edge Rankings

Stock Score Locked: Want to See it?

Bulls vs Bears

FAQ

How do I buy Cue Biopharma (CUE) stock?

Who are Cue Biopharma (CUE) competitors?

What is the forecast, or price target, for Cue Biopharma (CUE) stock?

What is the current price for Cue Biopharma (CUE)?

Does Cue Biopharma (CUE) pay a dividend?

When is Cue Biopharma (NASDAQ:CUE) reporting earnings?

Is Cue Biopharma (CUE) going to split?

What sector and industry does Cue Biopharma (CUE) operate in?

Bulls vs Bears